Technetium Tc 99m Pyrophosphate: Clinical Trials

4 trials of Technetium Tc 99m Pyrophosphate, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 not yet recruiting, 1 recruiting. 2 Early Phase 1, 2 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Early Phase 12Completed 2
Phase 12Not yet recruiting 1, Recruiting 1
Phase 21Not yet recruiting 1

Follow Technetium Tc 99m Pyrophosphate: new trials by email Literature Review of Technetium Tc 99m Pyrophosphate trials Research Report on Technetium Tc 99m Pyrophosphate

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
[18F]FIDT-10b PET Imaging in Cardiac Amyloidosis
[18F]FIDT-10b, 99mTc-PYP - Transthyretin Cardiac Amyloidosis, Light Chain Cardiac Amyloidosis
Phase 1 / Phase 2Not yet recruitingPeking Union Medical College Hospital482026-08-312026-09-23
A Phase 1 Study of 99mTc-p5+14 in Healthy Volunteers and Patients With AL or ATTR Systemic Amyloidosis
99mTc-p5+14 is an amyloid reactive peptide labeled with technetium-99m., 99mTc-Pyrophosphate - Systemic Amyloidosis
Phase 1RecruitingUniversity of Tennessee Graduate School of Medicine312023-09-182026-07-24
Prevalence of Transthyretin Cardiac Amyloidosis in Clinically Significant Aortic Stenosis
99mTc-PYP - Aortic Stenosis, Transthyretin Amyloidosis
Early Phase 1CompletedMayo Clinic42023-07-142024-08-07
Transthyretin Cardiac Amyloidosis in HFpEF
99mTc-PYP - Heart Failure With Preserved Ejection Fraction
Early Phase 1CompletedMayo Clinic2872017-12-012021-03-19

Conditions studied

Amyloidosis (2)  ·  Amyloidosis, Hereditary, Transthyretin-Related (1)  ·  Aortic Valve Stenosis (1)  ·  Heart Failure (1)  ·  Heart Failure, Diastolic (1)  ·  Immunoglobulin Light-chain Amyloidosis (1)

Sponsors

Mayo Clinic (2)  ·  Peking Union Medical College Hospital (1)  ·  University of Tennessee Graduate School of Medicine (1)

Countries

United States (3)  ·  China (1)

Top investigators

Jonathan S Wall, PhD (1)  ·  Omar F Abou Ezzeddine (1)  ·  Omar F Abou Ezzeddine, MD (1)